Article
Establishment of induced pluripotent stem cell lines from an ARVC patient carrying a heterozygous variant in LAMA2 gene.
Stem cell research - 1 Feb 2023
Wang Yue, Fang Yibing, Wang Yabo, Xia Shutao, Zhang Donghui, An Qi, Li Yifei, Luo Shuhua
Abstract excerpt
Using peripheral blood mononuclear cell (PBMC) reprogramming technology, a human-induced pluripotent stem cell (iPSC) line was produced from a patient who presents classic clinical features of arrhythmogenic right ventricular cardiomyopathy (ARVA) and carries a de novo laminin subunit alpha 2 (LAMA2) heterozygous mutation (NM_000426.3: c.8842G > A, p.G2948S). This mutation was not inherited from his parents, who...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
